BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25046247)

  • 1. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.
    Zi FM; He JS; Li Y; Wu C; Wu WJ; Yang Y; Wang LJ; He DH; Yang L; Zhao Y; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
    Cancer Biol Ther; 2014 Oct; 15(10):1413-22. PubMed ID: 25046247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].
    Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):84-8. PubMed ID: 18315906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells.
    Kikuchi J; Koyama D; Mukai HY; Furukawa Y
    Int J Hematol; 2014 Jun; 99(6):726-36. PubMed ID: 24706190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].
    Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):234-7. PubMed ID: 18843976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
    Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
    BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.
    Perez LE; Parquet N; Meads M; Anasetti C; Dalton W
    Eur J Haematol; 2010 Mar; 84(3):212-22. PubMed ID: 19922463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
    Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
    Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
    Chen L; Wang S; Zhou Y; Wu X; Entin I; Epstein J; Yaccoby S; Xiong W; Barlogie B; Shaughnessy JD; Zhan F
    Blood; 2010 Jan; 115(1):61-70. PubMed ID: 19837979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.
    Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD
    Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
    Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
    Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
    Ge Y; Zhan F; Barlogie B; Epstein J; Shaughnessy J; Yaccoby S
    Br J Haematol; 2006 Apr; 133(1):83-92. PubMed ID: 16512833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation.
    Chung KM; Hsu SC; Chu YR; Lin MY; Jiaang WT; Chen RH; Chen X
    PLoS One; 2014; 9(2):e88772. PubMed ID: 24551161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis.
    Abdi J; Mutis T; Garssen J; Redegeld FA
    PLoS One; 2014; 9(5):e96608. PubMed ID: 24794258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells].
    Wang H; Liu X; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):531-7. PubMed ID: 18549623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
    Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression.
    Hao M; Zhang L; An G; Meng H; Han Y; Xie Z; Xu Y; Li C; Yu Z; Chang H; Qiu L
    Leuk Lymphoma; 2011 Sep; 52(9):1787-94. PubMed ID: 21534877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade.
    Wen X; He X; Jiao F; Wang C; Sun Y; Ren X; Li Q
    Oncol Res; 2017 Apr; 25(4):629-640. PubMed ID: 27983931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.